Bates M.E., Bowden S.C., Barry D. Neurocognitive impairment associated with alcohol use disorders: Implications for treatment // Experimental and Clinical Psychopharmacology. 2002. Vol. 10, No. 3. Р. 193–212. https://doi.org/10.1037/1064-1297.10.3.193..
DOI: 10.1037/1064-1297.10.3.193

Bruijnen C.J.W.H., Dijkstra B.A.G., Walvoort S.J.W., Markus W., Van Der Nagel J.E.L., Kessels R.P.C., de Jong C.A.J. Prevalence of cognitive impairment in patients with substance use disorder // Drug and Alcohol Review. 2019. Vol. 38, No. 4. Р. 435–442. https://doi.org/10.1111/dar.12922..
DOI: 10.1111/dar.12922

Copersino M.L., Schretlen D.J., Fitzmaurice G.M., Lukas S.E., Faberman J., Sokoloff J., Weiss R.D. Effects of cognitive impairment on substance abuse treatment attendance: Predictive validation of a brief cognitive screening measure // American Journal of Drug and Alcohol Abuse. 2012. Vol. 38, No. 3. Р. 246–250. https://doi.org/10.3109/00952990.2012.670866..
DOI: 10.3109/00952990.2012.670866

Noël X., Sferrazza R., Van Linden M Der., Paternot J., Verhas M., Hanak C., Pelc I., Verbanck P. Contribution of frontal cerebral blood flow measured by 99mTc-bistate spect and executive function deficits to predicting treatment outcome in alcohol-dependent patients // Alcohol and Alcoholism. 2002. Vol. 37, No. 4. Р. 347–354. https://doi.org/10.1093/alcalc/37.4.347..
DOI: 10.1093/alcalc/37.4.347

Bates M.E., Pawlak A.P., Tonigan J.S., Buckman J.F. Therapeutic mechanisms of change // Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors. 2010. Vol. 20, No. 3. Р. 241–253. https://doi.org/10.1037/0893-164X.20.3.241..
DOI: 10.1037/0893-164X.20.3.241

Sømhovd M., Hagen E., Bergly T., Arnevik EA. The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment // Heliyon. 2019. Vol. 5, No. 3. Р. e01282. https://doi.org/10.1016/j.heliyon.2019.e01282..
DOI: 10.1016/j.heliyon.2019.e01282

Киржанова В.В., Григорова Н.И., Киржанов В.Н., Сидорюк О.В. Состояние и деятельность наркологической службы в Российской Федерации в 2017 году: Аналитический обзор. М.: ФГБУ «НМИЦ ПН им. В.П. Сербского» Минздрава России. 2019. 196 р. Ссылка активна на 09.12.2020. http://nncn.serbsky.ru/wp-content/uploads/2019/03/Анал_обзор_нарко_2017_фин-1-1.pdfhttp://nncn.serbsky.ru/wp-content/uploads/2019/03/Анал_обзор_нарко_2017_фин-1-1.pdf

Киржанова В.В., Григорова Н.И., Киржанов В.Н., Сидорюк О.В. Состояние и деятельность наркологической службы в Российской Федерации в 2017 году: Аналитический обзор. М.: ФГБУ «НМИЦ ПН им. В.П. Сербского» Минздрава России. 2019. 196 р. Ссылка активна на 09.12.2020. http://nncn.serbsky.ru/wp-content/uploads/2019/03/Анал_обзор_нарко_2017_фин-1-1.pdfhttp://nncn.serbsky.ru/wp-content/uploads/2019/03/Анал_обзор_нарко_2017_фин-1-1.pdf

Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter Study // Neurology. 2010. Vol. 75, No. 23. Р. 2087–2096. https://doi.org/10.1212/WNL.0b013e318200d727..
DOI: 10.1212/WNL.0b013e318200d727

Gisslén M., Price R.W., Nilsson S. The definition of HIV-associated neurocognitive disorders: Are we overestimating the real prevalence? // BMC Infectious Diseases. 2011. Vol. 11. Р. 2–5. https://doi.org/10.1186/1471-2334-11-356..
DOI: 10.1186/1471-2334-11-356

Nightingale S., Winston A. Measuring and managing cognitive impairment in HIV // AIDS. 2017. Vol. 31. S165–172. https://doi.org/10.1097/QAD.0000000000001402..
DOI: 10.1097/QAD.0000000000001402

Alford K, Vera J.H. Cognitive Impairment in people living with HIV in the ART era: A Review // British Medical Bulletin. 2018. Vol. 127, No. 1. Р. 55–68. https://doi.org/10.1093/bmb/ldy019..
DOI: 10.1093/bmb/ldy019

Kennedy C.A., Zerbo E. HIV-related neurocognitive disorders and drugs of abuse: mired in confound, surrounded by risk // Current Addiction Reports. 2014. Vol. 1, No. 3. Р. 229–236. https://doi.org/10.1007/s40429-014-0028-5..
DOI: 10.1007/s40429-014-0028-5

Norman LR, Basso M, Kumar A, Malow R. Neuropsychological consequences of HIV and substance abuse: a literature review and implications for treatment and future research // Current drug abuse reviews. 2009. Vol. 2, No. 2. Р. 143–56. https://doi.org/10.1038/s41598-019-39414-9..
DOI: 10.1038/s41598-019-39414-9

Winston A, Spudich S. Cognitive disorders in people living with HIV // The Lancet HIV. 2020. Vol. 7, No. 7. Р. e504–13. https://doi.org/10.1016/S2352-3018(20)30107-7..
DOI: 10.1016/S2352-3018(20)30107-7

To W.T., Vanheule S., Vanderplasschen W., Audenaert K., Vandevelde S. Screening for intellectual disability in persons with a substance abuse problem: Exploring the validity of the Hayes Ability Screening Index in a Dutch-speaking sample // Research in Developmental Disabilities. 2015. Vol. 36. Р. 498–504. https://doi.org/10.1016/j.ridd.2014.10.046..
DOI: 10.1016/j.ridd.2014.10.046

Куков К., Радкова Д.М., Николова Д. Обзор методик нейропсихологического скрининга когнитивных функций и особенности их применения при исследовании больных с ВИЧ-инфекцией и синдромом приобретенного иммунодефицита // Вестник Южно-Уральского государственного университета. Серия: Психология. 2016. Т. 9, № 3. С. 16–23. https://doi.org/10.14529/psy160302..
DOI: 10.14529/psy160302

Verdejo-Garcia A., Lorenzetti V., Manning V., Piercy H., Bruno R., Hester R., Pennington D., Tolomeo S., Arunogiri S., Bates M.E., BowdenJones H., Campanella S., Daughters S.B., Kouimtsidis C., Lubman D.I., Meyerhoff D.J., Ralph A., Rezapour T., Tavakoli H., Zare-Bidoky M., Zilverstand A., Steele D., Moeller S.J., Paulus M., Baldacchino A., Ekhtiari H. A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine // Frontiers in Psychiatry. 2019. Vol. 10. Р. 1–23. https://doi.org/10.3389/fpsyt.2019.00877..
DOI: 10.3389/fpsyt.2019.00877

Lookatch S.J., Elledge L.C., Anderson S., Shorey R.C., Stuart G.L., Moore T.M. Cognitive and psychological changes during 28-day residential substance use treatment // Addiction Research and Theory. 2017. Vol. 25, No. 4. Р. 334–341. https://doi.org/10.1080/16066359.2017.1281408..
DOI: 10.1080/16066359.2017.1281408

Ramey T., Regier P.S. Cognitive impairment in substance use disorders // CNS Spectrums. 2019. Vol. 24, No. 1. Р. 102–113. https://doi.org/10.1017/S1092852918001426..
DOI: 10.1017/S1092852918001426

Kwako L.E., Momenan R., Litten R.Z., Koob G.F., Goldman D. Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders // Biological Psychiatry. 2016. Vol. 80, No. 3. Р. 179–189. https://doi.org/10.1016/j.biopsych.2015.10.024..
DOI: 10.1016/j.biopsych.2015.10.024

Antinori A., Arendt G., Becker JT., Brew BJ., Byrd DA., Cherner M., Clifford DB., Cinque P., Epstein LG., Gisslen M., Grant I., Heaton RK., Joseph J., Marra CM., Mcarthur JC., Nunn M., Price RW., Pulliam L., Robertson KR., Sacktor N., Valcour V., Wojna VE., Mount T., Medical S., Diego S., Hospital SR., Seattle W., Disorders N., Francisco S., Program N., Campus MS. Updated research nosology for HIV-associated neurocognitive disorders // Neurology. 2007. Vol. 69, No. 18. Р. 1789–1799. https://doi.org/10.1212/01.WNL.0000287431.88658.8b..
DOI: 10.1212/01.WNL.0000287431.88658.8b

Barry D., Petry N.M. Predictors of decision-making on the Iowa Gambling Task: Independent effects of lifetime history of substance use disorders and performance on the Trail Making Test // Brain and Cognition. 2008. Vol. 663. Р. 243–252. https://doi.org/10.1016/j.bandc.2007.09.001..
DOI: 10.1016/j.bandc.2007.09.001

Dolan S.L., Bechara A., Nathan P.E. Executive dysfunction as a risk marker for substance abuse: the role of impulsive personality traits // Behavioral Sciences & the Law. 2008. Vol. 26. Р. 799–822. https://doi.org/10.1002/bsl..
DOI: 10.1002/bsl

Fernández-Serrano M.J., Pérez-García M., Schmidt Río-Valle J., Verdejo-García A. Neuropsychological consequences of alcohol and drug abuse on different components of executive functions // Journal of Psychopharmacology. 2010. Vol. 24, No. 9. Р. 1317–1332. https://doi.org/10.1177/0269881109349841..
DOI: 10.1177/0269881109349841

Verdejo-García A., Bechara A., Recknor EC., Pérez-García M. Executive dysfunction in substance-dependent individuals during drug use and abstinence: An examination of the behavioral, cognitive and emotional correlates of addiction // Journal of the International Neuropsychological Society. 2006. Vol. 12, No. 3. Р. 405–415. https://doi.org/10.1017/S1355617706060486..
DOI: 10.1017/S1355617706060486

Goldstein R.Z., Leskovjan A.C., Hoff A.L., Hitzemann R., Bashan F., Khalsa S.S., Wang G.J., Fowler J.S., Volkow N.D. The severity of neuropsychological impairment in cocaine and alcohol addiction: Association with metabolism in the prefrontal cortex // Neuropsychology. 2004. Vol. 42, No. 11. Р. 1447–1458. https://doi.org/10.1016/j.neuropsychologia.2004.04.002.
DOI: 10.1016/j.neuropsychologia.2004.04.002

Hagen E., Erga A.H., Hagen K.P., Nesvåg S.M., McKay J.R., Lundervold A.J., Walderhaug E. Assessment of executive function in patients with substance use disorder: A comparison of inventory- and performance-based assessment // Journal of Substance Abuse Treatment [Internet]. 2016. Vol. 66. Р. 1–8. https://doi.org/10.1016/j.jsat.2016.02.010..
DOI: 10.1016/j.jsat.2016.02.010

Hagen E., Erga A.H., Hagen K.P., Nesvåg S.M., McKay J.R., Lundervold A.J., Walderhaug E. Assessment of executive function in patients with substance use disorder: A comparison of inventory- and performance-based assessment // Journal of Substance Abuse Treatment [Internet]. 2016. Vol. 66. Р. 1–8. https://doi.org/10.1016/j.jsat.2016.02.010..
DOI: 10.1016/j.jsat.2016.02.010

Verdejo-Garcia A., Lorenzetti V., Manning V., Piercy H., Bruno R., Hester R., Pennington D., Tolomeo S., Arunogiri S., Bates ME., BowdenJones H., Campanella S., Daughters S.B., Kouimtsidis C., Lubman DI., Meyerhoff DJ., Ralph A., Rezapour T., Tavakoli H., Zare-Bidoky M., Zilverstand A., Steele D., Moeller SJ., Paulus M., Baldacchino A., Ekhtiari H. A Roadmap for Integrating Neuroscience Into Addiction Treatment: A Consensus of the Neuroscience Interest Group of the International Society of Addiction Medicine // Frontiers in Psychiatry. 2019. Vol. 10 (December). Р. 1–23. https://doi.org/10.3389/fpsyt.2019.00877..
DOI: 10.3389/fpsyt.2019.00877

Koob G.F., Le Moal M. Drug abuse: Hedonic homeostatic dysregulation // Science. 1997. Vol. 278, No. 5335. Р. 52–58. https://doi.org/10.1126/science.278.5335.52..
DOI: 10.1126/science.278.5335.52

Moher D., Liberati A., Tetzlaff J., Altman DG., Altman D., Antes G., Atkins D., Barbour V., Barrowman N., Berlin JA., Clark J., Clarke M., Cook D., D’Amico R., Deeks JJ., Devereaux PJ., Dickersin K., Egger M., Ernst E., Gøtzsche PC., Grimshaw J., Guyatt G., Higgins J., Ioannidis J.P.A., Kleijnen J., Lang T., Magrini N., McNamee D., Moja L., Mulrow C., Napoli M., Oxman A., Pham B., Rennie D., Sampson M., Schulz KF., Shekelle PG., Tovey D., Tugwell P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement // PLoS Medicine. 2009. Vol. 6, No. 7. Р. e1000097. https://doi.org/10.1371/journal.pmed.1000097..
DOI: 10.1371/journal.pmed.1000097

Березина А.А., Гвоздецкий А.Н., Климанова С.Г., Трусова А.В. Особенности принятия решений и эмоциональной регуляции у лиц с зависимостью от алкоголя // Вопросы наркологии. 2017. № 12. С. 133–144.

Полунина А.Г., Давыдов Д.М., Брюн Е.А. Нейропсихологические исследования когнитивных нарушений при алкоголизме и наркомании // Психологический журнал. 2004. Т. 25, № 5. С. 70–76.

Адрианова Е.Д., Дамулин И.В., Сиволап Ю.П. Когнитивные расстройства при алкоголизме // Наркология. 2013. Т. 12, № 6. С. 79–85.

Беляков Н.А., Медведев С.В., Трофимова Т.Н., Рассохин В.В., Дементьева Н.Е., Шеломов С.А. Механизмы поражения головного мозга при ВИЧ-инфекции // Вестник Российской академии медицинских наук. 2012. Т. 67, № 9. С. 4–12. https://doi.org/10.15690/vramn.v67i9.400..
DOI: 10.15690/vramn.v67i9.400

Трофимова Т.Н., Катаева Г.В., Громова Е.А., Рассохин В.В., Боева Е.В., Симакина О.Е., Беляков Н.А. ВИЧ-ассоциированные нейрокогнитивные нарушения: диагностика, выявление причин и эффективность терапии // ВИЧ-инфекция и иммуносупрессии. 2018. Т. 10, № 4. С. 7–24. https://doi.org/10.22328/2077-9828-2018-10-4-7-24..
DOI: 10.22328/2077-9828-2018-10-4-7-24

Folstein M.F., Folstein S.E., McHugh P.R. «Mini-mental state»: a practical method for grading the cognitive state of patients for the clinician // Journal of psychiatric research. 1975. Vol. 12, No. 3. Р. 189–198. https://doi.org/10.3744/snak.2003.40.2.021..
DOI: 10.3744/snak.2003.40.2.021

Mioshi E., Dawson K., Mitchell J., Arnold R., Hodges J.R. The Addenbrooke’s Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening // International Journal of Geriatric Psychiatry. 2006. Vol. 21, No. 11. Р. 1078–1085. https://doi.org/https://doi.org/10.1002/gps.1610..
DOI: 10.1002/gps.1610

Ridley N., Batchelor J., Draper B., Demirkol A., Lintzeris N., Withall A. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination. Addenbrooke’s Cognitive Examination–Revised., and Montreal Cognitive Assessment // Journal of Clinical and Experimental Neuropsychology. 2018. Vol. 40, No. 2. Р. 107–122. https://doi.org/10.1080/13803395.2017.1316970..
DOI: 10.1080/13803395.2017.1316970

Wester A.J., Westhoff J., Kessels R.P.C., Egger J.I.M. The Montreal Cognitive Assessment (MoCA) is a measure of severity of amnesia in patients with alcohol-related cognitive impairments and Korsakov syndrome // Clinical Neuropsychiatry. 2013. Vol. 10, No. 3–4. Р. 134–141.

Sømhovd M., Hagen E., Bergly T., Arnevik E.A. The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment // Heliyon. 2019. Vol. 5, No. 3. Р. e01282. https://doi.org/10.1016/j.heliyon.2019.e01282..
DOI: 10.1016/j.heliyon.2019.e01282

Manning V., Gomez B., Guo S., Wong K.E., Assam P.N., Shih E., Chan-Yen. International Archives of Addiction Research and Medicine Screening for Cognitive Impairment in Asian Substance-Dependent Patients: MMSE versus MoCA // Int. Arch. Addict. Res. Med. 2016. Vol. 2, No. 2. Р. 1–5.

Ridley N., Batchelor J., Draper B., Demirkol A., Lintzeris N., Withall A. Cognitive screening in substance users: Diagnostic accuracies of the Mini-Mental State Examination, Addenbrooke’s Cognitive Examination–Revised, and Montreal Cognitive Assessment // Journal of Clinical and Experimental Neuropsychology. 2018. Vol. 40, No. 2. Р. 107–122. https://doi.org/10.1080/13803395.2017.1316970..
DOI: 10.1080/13803395.2017.1316970

Toledo-Fernández A., Villalobos-Gallegos L., Marín-Navarrete R. Is the Mini-Mental State Examination (MMSE) useful for eligibility screening of research participants with substance use disorder? // Revista Internacional de Investigación en Adicciones. 2017. Vol. 2, No. 1. Р. 39–44. https://doi.org/10.28931/riiad.2016.1.06..
DOI: 10.28931/riiad.2016.1.06

Copersino M.L., Fals-Stewart W, Fitzmaurice G, Schretlen DJ, Sokoloff J, Weiss RD. Rapid cognitive screening of patients with substance use disorders // Experimental and clinical psychopharmacology. 2009. Vol. 17, No. 5. Р. 337–344. https://doi.org/10.1038/jid.2014.371..
DOI: 10.1038/jid.2014.371

Alarcon R., Nalpas B., Pelletier S., Perney P. MoCA as a Screening Tool of Neuropsychological Deficits in alcohol-dependent Patients // Alcoholism: Clinical and Experimental Research. 2015. Vol. 39, No. 6. Р. 1042–1048. https://doi.org/10.1111/acer.12734..
DOI: 10.1111/acer.12734

Ewert V., Pelletier S., Alarcon R., Nalpas B., Donnadieu-Rigole H., Trouillet R., Perney P. Determination of MoCA Cutoff Score in Patients with Alcohol Use Disorders // Alcoholism: Clinical and Experimental Research. 2018 Vol. 42, No. 2. Р. 403–412. https://doi.org/10.1111/acer.13547..
DOI: 10.1111/acer.13547

Toledo-Fernández A, Marín-Navarrete R, Villalobos-Gallegos L, Salvador-Cruz J, Benjet C, Roncero C. Exploring the prevalence of substanceinduced neurocognitive disorder among polysubstance users, adding subjective and objective evidence of cognitive impairment // Psychiatry Research. 2020. Vol. 288, March. Р. 112944. https://doi.org/10.1016/j.psychres.2020.112944..
DOI: 10.1016/j.psychres.2020.112944

Fazeli P.L., Casaletto K.B., Paolillo E., Moore R.C., Moore D.J., the HNRP Group. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning // Journal of Clinical and Experimental Neuropsychology. 2017. Vol. 39, No. 9. Р. 842–853. https://doi.org/10.1080/13803395.2016.1273319..
DOI: 10.1080/13803395.2016.1273319

Maillard A., Cabé N., Viader F., Pitel A.L. Neuropsychological deficits in alcohol use disorder: impact on treatment // Cognition and addiction [Academic Press]. 2020. Р. 103–128. https://doi.org/10.1016/B978-0-12-815298-0.00008-3..
DOI: 10.1016/B978-0-12-815298-0.00008-3